Marktgröße für choroidale Neovaskularisation, Anteilsanalyse bis 2025-2031
Choroidal Neovascularization Market Report Analysis
Choroidal Neovascularization Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million

Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Affitech A/S
- F. Hoffmann-La Roche Ltd.
- Lpath, Inc.
- Mat Biopharma
- Promedior, Inc.
- Regeneron Pharmaceuticals, Inc.
- Resolvyx Pharmaceuticals, Inc
- Sanwa Kagaku Kenkyusho Co., Ltd.
Regional Overview

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika
- Naher Osten und Afrika
Market Segmentation

- intravenös
- intravitreal

- Nordamerika
- Europa
- Asien-Pazifik
- Süd- und Mittelamerika